Podcast: Non-binding Guidance: Real-World Evidence in Drug Development and FDA Submissions
The Free Speech Clause of the First Amendment prevailed in the latest challenge to the FDA's prohibition against marketing FDA-approved drugs for off-label (or non-FDA-approved) uses. Applying the Second Circuit’s...more